A randomised phase II trial of temozolomide with or without cannabinoids in patients with recurrent glioblastoma (ARISTOCRAT): protocol for a multi-centre, double-blind, placebo-controlled trial

被引：0
|
作者：
Divyalakshmi Bhaskaran
Joshua Savage
Amit Patel
Fiona Collinson
Rhys Mant
Florien Boele
Lucy Brazil
Sara Meade
Peter Buckle
Siân Lax
Lucinda Billingham
Susan C. Short
机构：
[1] University of Leeds,School of Medicine
[2] Leeds Teaching Hospitals NHS Trust,Cancer Research UK Clinical Trials Unit (CRCTU), Institute of Cancer & Genomic Sciences
[3] University of Birmingham,undefined
[4] Guy’s and St Thomas’ NHS Foundation Trust,undefined
[5] University Hospitals Birmingham Foundation Trust,undefined
[6] The Brain Tumour Charity,undefined
来源：
BMC Cancer | / 24卷
关键词：
Randomised phase II trial; Glioblastoma; Cannabinoids; Sativex; Nabiximols; Brain cancer; Tumour; Temozolomide; Progression free survival; Overall survival; Adverse events;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] A randomised phase II trial of temozolomide with or without cannabinoids in patients with recurrent glioblastoma (ARISTOCRAT): protocol for a multi-centre, double-blind, placebo-controlled trial
    Bhaskaran, Divyalakshmi
    Savage, Joshua
    Patel, Amit
    Collinson, Fiona
    Mant, Rhys
    Boele, Florien
    Brazil, Lucy
    Meade, Sara
    Buckle, Peter
    Lax, Sian
    Billingham, Lucinda
    Short, Susan C.
    BMC CANCER, 2024, 24 (01)
  • [2] Synbiotics in patients at risk for spontaneous preterm birth: protocol for a multi-centre, double-blind, randomised placebo-controlled trial (PRIORI)
    Nulens, Katrien
    Papy, Els
    Tartaglia, Katrien
    Dehaene, Isabelle
    Logghe, Hilde
    Van Keirsbilck, Joachim
    Chantraine, Frederic
    Masson, Veronique
    Simoens, Eva
    Gysemans, Willem
    Bruckers, Liesbeth
    Lebeer, Sarah
    Allonsius, Camille Nina
    Oerlemans, Eline
    Steensels, Deborah
    Reynders, Marijke
    Timmerman, Dirk
    Devlieger, Roland
    Van Holsbeke, Caroline
    TRIALS, 2024, 25 (01)
  • [3] Fibrosing Alveolitis in scleroderma trial (FAST) - A multi-centre prospective randomised double-blind placebo-controlled trial.
    Hoyles, RK
    Ellis, RW
    Herrick, AL
    McHugh, NJ
    Foley, NM
    Pearson, SB
    Emery, P
    Veale, DJ
    Denton, CP
    Wells, AU
    Black, CM
    du Bois, RM
    ARTHRITIS AND RHEUMATISM, 2005, 52 (12): : 4110 - 4110
  • [4] A randomised, double-blind, placebo-controlled multi-centre phase III trial of XELIRI/FOLFIRI plus simvastatin for patients with metastatic colorectal cancer
    S H Lim
    T W Kim
    Y S Hong
    S-W Han
    K-H Lee
    H J Kang
    I G Hwang
    J Y Lee
    H S Kim
    S T Kim
    J Lee
    J O Park
    S H Park
    Y S Park
    H Y Lim
    S-H Jung
    W K Kang
    British Journal of Cancer, 2015, 113 : 1421 - 1426
  • [5] A randomised, double-blind, placebo-controlled multi-centre phase III trial of XELIRI/FOLFIRI plus simvastatin for patients with metastatic colorectal cancer
    Lim, S. H.
    Kim, T. W.
    Hong, Y. S.
    Han, S-W
    Lee, K-H
    Kang, H. J.
    Hwang, I. G.
    Lee, J. Y.
    Kim, H. S.
    Kim, S. T.
    Lee, J.
    Park, J. O.
    Park, S. H.
    Park, Y. S.
    Lim, H. Y.
    Jung, S-H
    Kang, W. K.
    BRITISH JOURNAL OF CANCER, 2015, 113 (10) : 1421 - 1426
  • [6] Safety, immunogenicity and efficacy assessment of HIV immunotherapy in a multi-centre, double-blind, randomised, Placebo-controlled Phase Ib human trial
    Boffito, Marta
    Fox, Julie
    Bowman, Christine
    Fisher, Martin
    Orkin, Chloe
    Wilkins, Edmund
    Jackson, Akil
    Pleguezuelos, Olga
    Robinson, Stuart
    Stoloff, Gregory A.
    Caparros-Wanderley, Wilson
    VACCINE, 2013, 31 (48) : 5680 - 5686
  • [7] DESIGNING AND DELIVERING A RANDOMISED CONTROLLED TRIAL OF MEDICINAL CANNABINOIDS IN RECURRENT GLIOBLASTOMA - THE ARISTOCRAT TRIAL
    Short, Susan
    Savage, Joshua
    Mant, Rhys
    Patel, Amit
    Buckle, Peter
    Meade, Sarah
    Boele, Florien
    Banks, Emma
    Brazil, Lucy
    Collinson, Fiona
    Billingham, Lucinda
    NEURO-ONCOLOGY, 2023, 25
  • [8] Tavipec® in acute rhinosinusitis: a multi-centre, double-blind, randomized, placebo-controlled, clinical trial
    Dejaco, Daniel
    Bocian-Sobkowska, Joanna
    Szymanski, Witold
    Zacke, Gabriele
    Hoeckner, Verena
    Riechelmann, Herbert
    RHINOLOGY, 2019, 57 (05) : 367 - 374
  • [9] Decreasing risk of psychosis by sulforaphane study protocol for a randomized, double-blind, placebo-controlled, clinical multi-centre trial
    Li, Zhixing
    Zhang, Tianhong
    Xu, Lihua
    Wei, Yanyan
    Tang, Yingying
    Hu, Qiang
    Liu, Xiaohua
    Li, Xiaolong
    Davis, John
    Smith, Robert
    Jin, Hua
    Wang, Jijun
    EARLY INTERVENTION IN PSYCHIATRY, 2021, 15 (03) : 585 - 594
  • [10] A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia
    Shiina, Akihiro
    Shirayama, Yukihiko
    Niitsu, Tomihisa
    Hashimoto, Tasuku
    Yoshida, Taisuke
    Hasegawa, Tadashi
    Haraguchi, Tadashi
    Kanahara, Nobuhisa
    Shiraishi, Tetsuya
    Fujisaki, Mihisa
    Fukami, Goro
    Nakazato, Michiko
    Iyo, Masaomi
    Hashimoto, Kenji
    ANNALS OF GENERAL PSYCHIATRY, 2010, 9
12345